NewsBenzingaGSK 젬퍼리 단독요법, 토요일 발표···제2상 AZUR-1 MSI-H/dMMR 직장암 임상시험에서 76% 완전관해율, 20% 중증 이상반응, 3% 치료중단 등 전반적으로 일관된 안전성 보여 GSK 젬퍼리 단독요법, 토요일 발표···제2상 AZUR-1 MSI-H/dMMR 직장암 임상시험에서 76% 완전관해율, 20% 중증 이상반응, 3% 치료중단 등 전반적으로 일관된 안전성 보여 Benzinga 2026.10.26 07:32 (GMT+0) Open on Benzinga Other news BMO Capital Initiates Coverage On FirstEnergy with Outperform Rating, Announces Price Target of $50 Why Surgery Partners Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket Support for semiconductor stocks could be as much as 15% lower than current levels, says Morgan Stanley Weekly Market Pulse: Where The Puck Will Be Amcor’s Quarterly Earnings Preview: What You Need to Know Apple's Design Team Didn't Want Touchscreen Macs, But Tim Cook and John Ternus Had Other Ideas: Report
Support for semiconductor stocks could be as much as 15% lower than current levels, says Morgan Stanley
Apple's Design Team Didn't Want Touchscreen Macs, But Tim Cook and John Ternus Had Other Ideas: Report
